Patanjali Ayurved did not mention that its new medicine kit was developed for COVID-19 when it applied for a license, an official of the Uttarakhand government said on Wednesday.
“As per Patanjali’s application, we issued them a license. They didn’t mention coronavirus, we only approved the license for immunity booster, cough and fever,” Hindustan Times quoted YS Rawat, Licence Officer at the Uttarakhand Ayurveda Department as saying.
“We’ll issue them a notice asking how they got permission to make the kit (for COVID-19),” he added.
Patanjali Ayurved on Tuesday launched Coronil’ and ‘Swasari’, its Ayurvedic medicines claiming to treat COVID-19 patients within 14 days.
“We conducted a clinical case study and clinical controlled trial and found 69 per cent of patients recovered in 3 days and 100 patients recovered in 7 days,” the company’s co-founder Ramdev said at the medicine’s launch in Haridwar.
But soon after the launch, the Ministry of Ayush asked the company to stop advertising the medicines until they were examined.
“Patanjali Ayurved Ltd has been asked to provide at the earliest details of the name and composition of the medicines being claimed for COVID treatment, site(s)/hospital(s), where the research study was conducted for COVID-19, protocol, sample size, Institutional Ethics Committee clearance, CTRI registration and results from data of the study and stop advertising/publicizing such claims till the issue is duly examined,” the Ministry of Ayush said in a statement.
“Ministry has also requested concerned State Licensing Authority of Uttrakhand Government to provide copies of license and product approval details of the Ayurvedic medicines being claimed for the treatment of COVID -19,” it added.